• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Celgene Corporation (CELG)

    -NasdaqGS
    119.16 Down 1.71(1.41%) Jan 30, 4:00PM EST
    |After Hours : 119.37 Up 0.21 (0.18%) Jan 30, 7:24PM EST
    Add to Portfolio
    Prev Close:120.87
    Open:119.49
    Bid:119.19 x 200
    Ask:N/A
    1y Target Est:132.65
    Beta:2.02
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:118.89 - 124.29
    52wk Range:66.85 - 124.60
    Volume:8,129,114
    Avg Vol (3m):5,181,440
    Market Cap:95.17B
    P/E (ttm):49.86
    EPS (ttm):2.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    CELGDown 1.41%95.17B
    JNJDown 2.19%280.30B

    Key Statistics

    Forward P/E (1 yr):18.94
    P/S (ttm):12.59
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.84
    Quarterly EPS Est (Mar-15) :1.06
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.96

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback